Shares of Carnival Corporation (NYSE: CCL) fell 2.7% through 10:35 a.m. EDT trading Tuesday after the cruise company announced, after close of trading yesterday, that it has closed on a "previously announced incremental first-priority senior secured term loan facility in an aggregate principal amount of $2.3 billion." Investors are presumably reacting to the reminder that Carnival Corporation carries a lot of debt -- nearly $25 billion more than it has cash on hand -- and now seems to be taking on $2.3 billion more. As Carnival explained yesterday, the entire proceeds of its new loan will be used to redeem a batch of "11.500% First-Priority Senior Secured Notes due 2023."
The company's oral COVID-19 treatment looks like a dud in the mild-to-moderate COVID-19 setting.
Sean Farrell, Fundstrat Head of Digital Asset Strategy, discusses the potential effects of the first Bitcoin-linked ETF on the NYSE from ProShares.
Atea Pharmaceuticals said Tuesday its Merck-rivaling antiviral Covid pill failed in a midstage test, leading AVIR stock to crash.
Shares of the crypto bank Silvergate Capital (NYSE: SI) had fallen roughly 10% as of 11:25 a.m. EDT after the company reported earnings results for the third quarter of the year. The bank has built a payments platform called the Silvergate Exchange Network (SEN), which allows two parties on the network to clear transactions instantaneously. This is particularly attractive for institutional traders and cryptocurrency exchanges because cryptocurrencies trade nonstop.
Photo by Towfiqu barbhuiya on Unsplash Broad agreement in the world of science can be a rarity. However, one thing that public health leaders active in the fight against COVID-19 can agree on, is the urgent need for oral, pill-based treatments that are effective at halting disease progression, can get — and keep — people out of the hospital and can reduce mortality. One key group of COVID-19 patients who are in desperate need of treatment options are those moderately severe patients in hospital
When Virgin Galactic (NYSE: SPCE) went public via SPAC merger in 2019, the company projected that 66 passengers would fly aboard the company's spacecraft in 2020 and another 646 in 2021. Investors recently got word that yet another delay is hitting Virgin Galactic, and at best we will see a small number of revenue-generating flights in 2022, assuming no more delays.
These companies produce the only thing that matters.
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. In the following paragraphs, we find out […]
(Bloomberg) -- Petroleo Brasileiro SA investors excluded from its $2.95 billion “carwash” corruption settlement in the U.S. are signing up for a class-action case in the Netherlands -- where the Brazilian oil producer has failed to get the lawsuit thrown out on procedural grounds.Most Read from BloombergGoogle’s Biggest Moonshot Is Its Search for a Carbon-Free FutureA $30 Billion Fortune Is Hiding in China’s Silicon ValleyThe Biggest Public Graveyard in the U.S. Is Becoming a ParkGoogle’s CEO: ‘
Yahoo Finance's Jennifer Schonberger breaks down what to know about the Bitcoin futures ETF set to trade on the NYSE.
In the coronavirus vaccine market, several players -- including Moderna and Pfizer -- are currently benefiting from a first-mover advantage. One of them is Ocugen (NASDAQ: OCGN), a company that partnered with India-based Bharat Biotech to develop and market a COVID-19 vaccine called Covaxin. Like many other meme stocks, shares of Ocugen have been highly volatile since the beginning of the year -- and a recent regulatory breakthrough in India sent the company's stock soaring through the roof.
Although the benchmark S&P 500 tends to head higher over long periods of time, the stocks primarily responsible for pushing the widely followed index to new heights change regularly. As an example, nine of the 10 largest stocks by market cap in 2004 are no longer in the top 10 as of today. In fact, insurer AIG now sits around No. 250 in the market cap rankings.
In this article, we will be taking a look at the 12 best stocks that pay monthly dividends. To skip our detailed analysis of dividend investing, you can go directly to see the 5 Best Stocks That Pay Monthly Dividends. Dividend investing is a strategy that has long been integrated into investor circles, particularly by […]
In this article, we discuss the 10 companies Bezos is investing in. You can skip our detailed analysis of Jeff Bezos’ investment strategies, and go directly to read Jeff Bezos Stock Portfolio: 5 Companies Bezos Is Investing In. A Princeton graduate, Jeff Bezos founded e-commerce giant Amazon.com, Inc. (NASDAQ:AMZN) in 1994 with $10,000 of his […]
As the fears of the memory chip price declines start to materialize, the latest slump of Micron Technology (NASDAQ: MU) completely erased the yearly gains. While short-term headwinds shouldn't be a reason to "panic-sell, "prospective buyers should carefully evaluate upsides vs. downsides in their investment time frame.
In this article, we will take a look at the 11 best genomic stocks to buy now. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Genomic Stocks to Buy Now. Genomics is a branch of biology that studies the structure, function, evolution, mapping, and editing of genomes, […]
Wedbush Securities senior equity analyst Ygal Arounian discusses his rating downgrade on shares of Zillow Group, which have been under pressure ever since the company announced it would stop buying houses for the rest of the year, and what the news could mean for Opendoor.
R "Ray" Wang, Constellation Research Principal Analyst & Founder, joins Yahoo Finance to discuss the latest product releases from Apple ahead of the holiday season.
Although the computer chip shortage wrecked third-quarter auto sales by causing third quarter auto sales to tumble, the market still finds an investment in Ford (NYSE: F) to be intriguing. Ford's sales for the period were hurt along with most everyone else's, but it was actually able to beat expectations and management says sales improved as the quarter progressed. Because the automaker also continued its dominance in the truck market and sales of its electric vehicles are revving up, it's no wonder everyone is talking about Ford's stock.